10.9  0 (0%)		09-16 14:05
Open: 10.93 High: 10.93 Volume: 5,540		Pre. Close: 10.8999 Low: 10.885 Market Cap: 268(M)

Short term
Mid term
Targets	6-month :	12.78	1-year :	14.93
Resists	First :	10.94	Second :	12.78
Pivot price	10.86
Supports	First :	10.86	Second :	10.81
MAs	MA(5) :	10.88	MA(20) :	10.85
	MA(100) :	10.75	MA(250) :	10.59
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	53.8	D(3) :	50
RSI	RSI(14): 64.8
52-week	High :	10.94	Low :	10.34

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TDAC ] has closed below upper band by 14.4%. Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	10.96 - 11	11 - 11.05
Low:	10.74 - 10.79	10.79 - 10.84
Close:	10.81 - 10.89	10.89 - 10.97

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

Wed, 19 Aug 2026
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC - Business Wire

Fri, 14 Aug 2026
Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC - Stock Titan

Sat, 01 Aug 2026
ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment - Pulse 2.0

Tue, 28 Jul 2026
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment - Moomoo

Tue, 28 Jul 2026
ProLogium and Translational Development Acquisition Corp. - globenewswire.com

Mon, 22 Jun 2026
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	19 (M)
Shares Float	15 (M)
Held by Insiders	0 (%)
Held by Institutions	79 (%)
Shares Short	36 (K)
Shares Short P.Month	5 (K)

EPS	0.25
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.31
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-0.5 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-40.6 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	41.92
PEG Ratio	0
Price to Book value	-36.34
Price to Sales	0
Price to Cash Flow	-247.81

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.